Bayer Settles Roundup Cancer Lawsuits

Bayer's Five-Point Plan

In response to ongoing Roundup cancer lawsuits, Bayer announced a five-point plan on May 27, 2021, to address potential future claims:

• Establish an independent claims process to resolve outstanding and future claims.
• Create a science advisory panel to provide input on the health and safety of glyphosate.
• Invest in research on the long-term health effects of glyphosate.
• Work with regulatory agencies to ensure the safe use of glyphosate.
• Engage with stakeholders to address concerns about glyphosate.

Legal Victories for Bayer

Bayer has recently achieved several legal victories in its fight to limit liability from Roundup claims: * On August 15, 2021, the Third Circuit Court of Appeals issued a favorable ruling in Schaffner v. Bayer, upholding the dismissal of a lawsuit alleging that Roundup caused cancer. * On July 29, 2021, Bayer won a jury verdict in a Roundup cancer lawsuit in Philadelphia, with the jury finding that the plaintiff's cancer was not caused by Roundup.

Settlement of Roundup Cancer Lawsuits

Bayer announced on June 24, 2023, that it had reached an agreement to settle approximately 100,000 Roundup cancer lawsuits. The settlement includes a $10 billion fund to compensate individuals who have developed cancer after using Roundup.

Conclusion

Bayer's ongoing efforts to address Roundup cancer lawsuits and its recent legal victories are significant developments in the ongoing litigation. The company's five-point plan and the settlement of 100,000 lawsuits demonstrate Bayer's commitment to resolving outstanding claims and addressing concerns about the safety of its products.